Ataluren NEW
| Price | $32 | $52 | $85 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-11 |
Product Details
| Product Name: Ataluren | CAS No.: 775304-57-9 |
| Purity: 99.45% | Supply Ability: 10g |
| Release date: 2026/05/11 |
Product Introduction
Bioactivity
| Name | Ataluren |
| Description | Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and older who are able to walk. |
| Cell Research | PTC124 (Ataluren) is prepared in DMSO and stored, and then diluted with appropriate medium (DMSO 1%) before use[2]. Duplicate samples of HEK293 cells harbouring LUC-190 (UGA) are incubated in the presence of 5?μM PTC124 (treated) or 1% DMSO (untreated) for 20?h. The cells are collected, washed twice in phosphate buffered saline (PBS), resuspended in sample buffer (Bio-Rad) and shipped on dry ice to Kendrick Laboratories for two-dimensional electrophoretic analysis Isoelectric focusing (pH?3.5-10) is carried out in glass tubes for 20,000 V-hours. One?μg of a tropomyosin internal standard is added to each sample. Second dimension SDS slab gel electrophoresis is carried out for approximately 6?h at 25?mA per gel. After electrophoresis, gels are transferred to PVDF paper. Computerized analysis of spot mobility used Phoretix software[2]. |
| In vitro | 0.01-3 μM PTC124 promoted dose-dependent through-reading of all three nonsense codons in HEK293 cells containing the LUC-190 nonsense allele, with the highest readings at UGA, followed by UAG, and then UAA, but it did not inhibit multiple proximal nonsense codons. 17 μM PTC124 was consistent with the experimental assay reported for the stable cell line, and the results of PTC124 (17 PTC124 (17 μM) promotes significant production of myotrophic proteins in primary myoblasts from patients with Duchenne-type muscular dystrophy (DMD) or MDXMDX mice expressing the nonsense allele of myotrophic dystrophic protease.PTC124 selectively promotes the readthrough of ribosomal premature termination codons, but not normal termination codons, even at concentrations substantially higher than those required to achieve maximal activity. PTC124 is a more potent nonsense inhibitor than gentamicin, which is active only at higher concentrations, and shows a 4- to 15-fold stimulation of read-through relative to the control.PTC124, similar to gentamicin, is most active at pyrimidines (especially cytosine, C) following nonsense codons. |
| In vivo | 0.01-3 μM PTC124 promoted dose-dependent through-reading of all three nonsense codons in HEK293 cells containing the LUC-190 nonsense allele, with the highest readings at UGA, followed by UAG, and then UAA, but it did not inhibit multiple proximal nonsense codons. 17 μM PTC124 was consistent with the experimental assay reported for the stable cell line, and the results of PTC124 (17 PTC124 (17 μM) promotes significant production of myotrophic proteins in primary myoblasts from patients with Duchenne-type muscular dystrophy (DMD) or MDXMDX mice expressing the nonsense allele of myotrophic dystrophic protease.PTC124 selectively promotes the readthrough of ribosomal premature termination codons, but not normal termination codons, even at concentrations substantially higher than those required to achieve maximal activity. PTC124 is a more potent nonsense inhibitor than gentamicin, which is active only at higher concentrations, and shows a 4- to 15-fold stimulation of read-through relative to the control.PTC124, similar to gentamicin, is most active at pyrimidines (especially cytosine, C) following nonsense codons. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+90% Corn Oil : 2.5 mg/mL (8.8 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 69 mg/mL (242.75 mM), Sonication is recommended. |
| Keywords | PTC-124 | PTC 124 | Inhibitor | inhibit | Cystic fibrosis transmembrane conductance regulator | CFTR | Autophagy | Ataluren |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Tamoxifen | Cysteamine hydrochloride | Guanidine hydrochloride | Hydroxychloroquine | Enzalutamide | Paeonol | Naringin | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Autophagy Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $100.00 |
VIP2Y
|
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
|
2026-06-15 | |
|
VIP4Y
|
shandong perfect biotechnology co.ltd
|
2026-03-27 | ||
| $100.00 |
VIP5Y
|
Hebei Dangtong Import and export Co LTD
|
2026-02-25 | |
|
VIP4Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2026-01-04 | ||
| $1.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-12-12 | |
| $50.00 |
Anhui Ruihan Technology Co., Ltd
|
2023-09-06 | ||
| $30.00 |
Henan Bao Enluo International TradeCo.，LTD
|
2023-07-28 | ||
|
Chengdu Hepu Pharmaceutical Technology Co. , Ltd
|
2022-05-06 | |||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
| $2.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY